SynGenSys
About:
SynGenSys creates product-specific libraries of synthetic genetic parts for next-generation biomedicines.
Website: https://syngensys.com/
Top Investors: Translink
Description:
SynGenSys creates product-specific libraries of synthetic genetic parts for next-generation biomedicines and biomanufacturing processes.
Total Funding Amount:
1.8M GBP
Headquarters Location:
Sheffield, Sheffield, United Kingdom
Founded Date:
2021-01-01
Founders:
Adam Brown, David James
Number of Employees:
1-10
Last Funding Date:
2024-04-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai